In conclusion, BARI-STEP, a randomized, placebo-controlled trial investigating the use of once-weekly semaglutide 2.4 mg in a post-bariatric patient population with a suboptimal clinical response, demonstrates that semaglutide 2.4 mg in patients with a suboptimal clinical response results in substantial, clinically relevant body weight reduction, and improvements in metabolic health and quality of life
If you have severe or rapidly worsening symptomssuch as trouble breathing, severe pain, confusion, fainting, uncontrolled bleeding, or signs of anaphylaxisseek emergency care immediately
Given its benefits for cardiovascular health, Semaglutide may be particularly beneficial for individuals with type 2 diabetes who are also at risk for cardiovascular events
Can you take phentermine and semaglutide together This question comes up constantly
Wegovy, a higher-dose formulation of Semaglutide, is specifically approved for weight management in individuals with obesity or those who are overweight with weight-related health conditions
How to inject: Using the Wegovy pen Before administering your Wegovy injection for the first time, read the Wegovy instructions in your patient information leaflet